Richard S. Judson

Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD.

Vion Pharmaceuticals, Inc. develops therapeutics for the treatment of cancer. The company was founded in March 1992 and is headquartered in New Haven, CT.

Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY.

Shire Regenerative Medicine, Inc. develops and commercializes living cell therapies. It manufactures and markets dermagraft, a bio-engineered skin substitute that assists in restoring damaged tissue and supports the body's natural healing process. The company was founded in 2004 and is headquartered in Westport, CT.

HighCape Partners Management LLC (HighCape Partners) is a private equity firm founded in 2013 by Kevin Rakin and Matt Zuga. The firm headquartered in Westport, Connecticut..

HighCape Capital Acquisition Corp. II operates as a blank check company. Its objective is effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination. The company was founded on February 9, 2021 and is headquartered in New York, NY.

HighCape Capital LP is a growth equity fund based in New York, NY. HighCape Capital is dedicated to helping innovative life sciences companies transition into successful and thriving organizations. HighCape Capital LP was founded in 2013 by Kevin L. Rakin and he has been the CEO since 2013.

CyVek, Inc. engages in the development of a novel, platform technology for measuring analytes in biological samples. It is a biotechnology company dedicated to the advancement of healthcare by empowering researchers and clinicians with a disruptive technology for performing multi-analyte immunoassays. The firm is a versatile platform that can be quickly and easily configured for diverse applications such as rapid diagnostic tests, multi-sample multi-analyte tests, or routine ELISA-like tests, for use in both research and clinical settings. The company offers an breadth of applications, from life science research to drug discovery, personalized medicine, diagnostics, and point-of-care testing. CyVek was founded by Per J. Hellsund, Rajiv Pandey and Marty Andrew Putnam in 2010 and is headquartered in Wallingford, CT.

454 Life Sciences Corp. engages in the provision of medical testing services to determine the nucleotide sequence of whole genomes. The company was founded by Jonathan M. Rothberg in 2000 and is headquartered in Branford, CT.

EMAlternatives LLC (EMAlternatives) is a private equity firm founded in 2007 by Christopher Wright, Ernest Lambers and Nick Morriss. The firm is headquartered in New York.

Colle Capital Partners (Colle Capital) is a venture capital firm founded in 2014 by Victoria Katsov Grace. The firm is headquartered in New York.

Fine Art Management Services Ltd. was founded in 2001 and provides support and advisory services for the art industry.

Collagen Matrix, Inc. design and manufactures extracellular matrices for tissue and organ repair and regeneration. The firm offers collagen and mineral-based finished medical devices in the areas of orthopedic-spine surgery, neurosurgery, oral surgery, and wound care. It provides DuraMatrix, Neuroflex, NeuroMatrix, OssiMend, and the Matrix Collagen. The company was founded by Shu-Tung Li in 1997 and is headquartered in Oakland, NJ.

The Sutton Trust provides education services. The company was founded by Peter Lampl in 1997 and is headquartered in London, the United Kingdom.

Convexity Scientific, Inc. provides healthcare services. Its product include flyp nebulizer, Flyp 22mm Mask Adapter, Flyp Care Box, and Flyp Medication Reservoir. The company was founded by Ralph Finger in January 2014 and is headquartered in Fairfield, CT.

Kestrel Partners LLP (Kestrel) is an investment manager and holding firm headquartered in London, UK. The firm was co-founded by Ari Zaphiriou-Zarifi, Max Royde and Oliver Scott in 2009. Kestrel provides investment management services to Kestrel Opportunities Fund (KOF), a US domiciled Special Purpose Vehicle, and separately managed accounts. Managed account services are offered to institutional investors, US high-net-worth individuals and family offices.

OMRIX Biopharmaceuticals, Inc. specializes in the manufacture and development of biosurgical and passive immunotherapy products. Its product range encompasses hemostatic, surgical, and immunotherapy solutions. The firm offers solutions for bleeding control, surgical operations, and biodefense applications. The company was founded by Robert Taub in 1995 and is headquartered in Somerville, NJ.

Canaan Management, Inc. (Canaan Management) is a venture capital firm founded in 1987 by Eric A. Young. The firm is headquartered in Westport, CT.

The Stevenson Group provides fulfillment and distribution services for a variety of products. It offers its services to pharmaceutical, biotechnology, medical devices, diagnostics, and healthcare services firms in the Americas and Europe. The company was founded by Stephen Steinman in 1979 and is headquartered in Fort Lee, NJ.

Cybrexa, Inc. develops molecule DNA repair inhibitors that directly target the tumor microenvironment. It develops and commercializes technologies that enables to improve cancer therapeutics. The company was founded by Per J. Hellsund, F. Kevin Didden, Ranjit S. Bindra, and Peter Glazer in 2016 and is headquartered in New Haven, CT.

Cheetah Medical, Inc. develops and markets non-invasive blood monitoring system. The firm offers cheetah sensors, staling SV and cheetah nicom devices. It provides noninvasive hemodynamic monitoring technologies which are designed for use in critical care, operating room and emergency department settings for a wide variety of patient populations. The company was founded by Hanan Keren in 2000 and is headquartered in Newton Center, MA.